Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Itaconix is a leading developer and manufacturer of sustainable, plant-based polymers used as high-performance ingredients in consumer products. Utilizing a proprietary technology platform, the company converts itaconic acid into functional polymers that serve as eco-friendly alternatives to petroleum-based chemicals in detergents, hygiene, and personal care applications. Itaconix is publicly traded on the London Stock Exchange and is recognized for its contributions to the green economy, providing essential building blocks for the next generation of sustainable consumer goods. The company's products, such as Itaconix® DSP™ and VELAFRESH™, are used by global brands to improve product safety and performance while reducing environmental impact.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ITX.